E0 ConsensusModerate confidencePEM ?Review-NarrativePeer-reviewedMachine draft
Practical management of chronic fatigue syndrome or myalgic encephalomyelitis in childhood.
Brigden, Amberly, Loades, Maria, Abbott, Anna et al. · Archives of disease in childhood · 2017 · DOI
Quick Summary
This article provides practical guidance on how doctors should diagnose and treat ME/CFS in children and teenagers. ME/CFS is a serious condition that affects at least 1 in 100 secondary school students in the UK, causing severe fatigue and limiting daily activities. Although effective treatments exist, many young people with ME/CFS don't get diagnosed or receive help they need.
Why It Matters
This guideline is important because ME/CFS in children remains underdiagnosed and undertreated despite affecting a substantial proportion of young people. By summarizing diagnostic criteria and evidence-based management approaches, it aims to improve clinical recognition and access to effective treatment, potentially reducing disability and improving outcomes in pediatric populations.
Observed Findings
- ME/CFS affects at least 1% of UK secondary school children
- Treatment options are available and effective for pediatric ME/CFS
- Many affected children do not receive a formal diagnosis
- Access to appropriate treatment remains limited despite its availability
Inferred Conclusions
- Early recognition and diagnosis of pediatric ME/CFS is critical but currently inadequate in clinical practice
- Clinicians need practical guidance to improve identification and management of ME/CFS in children and adolescents
- Closing the gap between evidence and practice could significantly reduce disability burden in young people
Remaining Questions
- What specific diagnostic and management protocols are most effective in pediatric populations?
- What barriers prevent children with ME/CFS from receiving timely diagnosis and treatment?
- How do outcomes differ between children who receive early treatment versus those diagnosed late?
- What long-term follow-up data exists for treated versus untreated pediatric ME/CFS patients?
What This Study Does Not Prove
This guideline does not provide new experimental evidence about disease mechanisms or generate comparative effectiveness data between specific treatments. It does not establish causation of ME/CFS or prove which individual interventions are most effective, as it synthesizes rather than generates primary research data.
Tags
Symptom:Post-Exertional MalaiseFatigue
Phenotype:Pediatric
Method Flag:PEM Not Defined